Rituxirel 500 Mg Injection

Name: Rituxirel 500 Mg Injection
Brand: MEDICINE PLANET

Get a Price/Quote

MOQ : 5 Vials

Rituxirel 500 Mg Injection Specification

Salt Composition
Rituximab

Indication
Non-Hodgkins lymphoma, chronic lymphocytic leukemia, autoimmune diseases

Dosage Form
Injection

Feature
Monoclonal antibody, anti-cancer

Ingredients
Rituximab 500 mg

Application
Therapeutic, Oncology

Physical Color/Texture
Clear to opalescent solution

Fermentation Smell
Odorless

Storage Instructions
Store at 2-8C

Shelf Life
36 months

Admin Route
Intravenous

Box Color
White-green

Brand Name
Rituxirel

Primary Use
Hospital supply

Sterile Preparation
Yes

Prescription Status
Rx only

Strength
500 mg

Packaging Size
1 vial

Unit Count
Single-use

Rituxirel 500 Mg Injection Trade Information

Minimum Order Quantity
5 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Rituxirel 500 Mg Injection

Discover the hot-selling Rituxirel 500 Mg Injection, a grandiose monoclonal antibody formulation designed for therapeutic excellence in oncology. Packaged in a commanding white-green single-use vial, this sterile intravenous preparation contains an inestimable 500 mg of Rituximab, offering targeted treatment for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and a spectrum of autoimmune diseases. Redeem exclusive offers now and benefit from its proven efficacy in hospital environments. As a leading exporter, manufacturer, and supplier from India, Rituxirel ensures quality, potent shelf life, and efficient hospital supply worldwide.

Site and Area of Application: Focused Oncology Care

Rituxirel 500 Mg Injection is administered intravenously, making it ideal for hospital use under professional supervision. Its area of application covers therapeutic settings targeting cancer, specifically non-Hodgkin's lymphoma and chronic lymphocytic leukemia, as well as certain autoimmune disorders. The injection is indicated for specialized treatment, offering inestimable value in managing malignancies and immune-related conditions. General use is strictly limited to licensed healthcare environments, ensuring both safety and precision in therapeutic delivery.

Ordering, Payment Terms & Domestic Market Reach

With swift order completion and express shipping, Rituxirel 500 Mg Injection is readily available for both domestic supply and export markets. Flexible payment terms guarantee seamless transactions for hospitals, clinics, and authorized buyers. As an in-demand product in India, this injection is supplied nationwide, with export orders easily accommodated. Samples may be available upon request, allowing healthcare providers to evaluate the commanding quality and efficacy before making a bulk commitment.

FAQ's of Rituxirel 500 Mg Injection:

Q: How should Rituxirel 500 Mg Injection be stored for optimal efficacy?

A: To maintain its stability and effectiveness, Rituxirel 500 Mg Injection should be stored at 2-8C and must not be frozen. Ensure it is kept in a refrigerator and protected from light.

Q: What is the primary medical use of Rituxirel 500 Mg Injection?

A: Rituxirel 500 Mg Injection is mainly used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and certain autoimmune diseases as prescribed by oncologists and healthcare professionals.

Q: When should Rituxirel 500 Mg Injection be administered?

A: This injection is given according to the dosing schedule set by a physician, usually within a hospital setting, following the confirmed diagnosis and treatment plan for eligible conditions.

Q: Where can Rituxirel 500 Mg Injection be purchased?

A: Rituxirel 500 Mg Injection can be ordered through licensed hospitals, clinics, or authorized suppliers. It is hot-selling domestically in India and also available through reputable exporters for international buyers.

Q: What is the process for ordering Rituxirel 500 Mg Injection samples?

A: Healthcare providers interested in evaluating the product can request samples from the manufacturer or authorized supplier. Sample availability and specific order terms can be clarified during the initial inquiry.

Q: How does Rituxirel's monoclonal antibody feature benefit patients?

A: Rituxirel contains Rituximab, a targeted monoclonal antibody that attaches to cancerous or overactive immune cells, aiding in their destruction and delivering measurable therapeutic benefit in malignancies and autoimmune diseases.